Congressional Grilling of Center for Tobacco Control Rare Opportunity For Taxpayers and Consumers

Brian King, head of the FDA's Center for Tobacco Control, faces a House hearing due to agency failures and political influence. The CTP's mishandling led to court criticism and whistleblower claims of neglecting science for politics. Amid demands for FDA reform, the agency's delays in approving safer nicotine products endanger public health. Transparency issues, administrative burdens, and public misperceptions on vaping worsen the situation. The hearing seeks accountability and urges the FDA to prioritize harm-reducing products, highlighting the need for structural reforms to protect millions of lives.